<DOC>
	<DOCNO>NCT02880982</DOCNO>
	<brief_summary>The investigator conduct n=5,400 Phase 3 , double-blind , individually randomise placebo-controlled clinical trial 5 year ' duration primary school City Cape Town Metropolitan Municipality , Western Cape Province , Republic South Africa . The primary objective trial determine whether weekly oral dose 0.25 mg ( 10,000 IU ) vitamin D3 , administer three year , reduces risk acquisition latent tuberculosis infection ( LTBI ) Cape Town primary schoolchildren . Statistical analysis perform intention-to-treat basis compare acquisition LTBI intervention vs. control arm three-year follow-up . The primary analysis logistic regression presence/absence LTBI follow-up outcome , adjust random effect school attendance .</brief_summary>
	<brief_title>Trial Vitamin D Supplementation Cape Town Primary Schoolchildren</brief_title>
	<detailed_description />
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Latent Tuberculosis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Pupil enrol Grades 14 participate primary school Age 611 year enrolment Pupil give write informed assent participate main trial Pupil 's parent / legal guardian give informed consent pupil participate main trial Age ≤5 year ≥12 year enrolment Previous positive InterferonGamma Release Assay ( IGRA ) Mantoux test Previous treatment LTBI active TB Clinical sign rickets History myalgia walk Inability rise unaided squatting position Taking supplemental vitamin D dose &gt; 400 IU daily equivalent previous month Diagnosis chronic illness asthma Suspected HIV infection child parent legal guardian decline child HIVtested Use regular medication asthma medication Plans move away study area within 3 year enrolment Unable swallow one placebo softgel ease Positive QuantiferonTB Gold Plus test screening</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>